OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models
Andreia M. Nunes, Monique Ramirez, Takako I. Jones, et al.
Disease Models & Mechanisms (2021) Vol. 14, Iss. 8
Open Access | Times Cited: 22

Showing 22 citing articles:

Facioscapulohumeral muscular dystrophy: the road to targeted therapies
Mara S. Tihaya, Karlien Mul, Judit Balog, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 2, pp. 91-108
Closed Access | Times Cited: 36

The Unexplored Role of Connexin Hemichannels in Promoting Facioscapulohumeral Muscular Dystrophy Progression
Macarena Díaz‐Ubilla, Mauricio A. Retamal
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 373-373
Open Access

Outcome Measures in Facioscapulohumeral Muscular Dystrophy Clinical Trials
Mehdi Ghasemi, Charles P. Emerson, Lawrence J. Hayward
Cells (2022) Vol. 11, Iss. 4, pp. 687-687
Open Access | Times Cited: 18

Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD
Valerio Caputo, Domenica Megalizzi, Carlo Fabrizio, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2687-2687
Open Access | Times Cited: 16

The FSHD jigsaw: are we placing the tiles in the right position?
Valentina Salsi, Gaetano Vattemi, Rossella Tupler
Current Opinion in Neurology (2023) Vol. 36, Iss. 5, pp. 455-463
Open Access | Times Cited: 9

Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping
Nikki M. McCormack, Kelsey A Calabrese, Christina M Sun, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102228-102228
Open Access | Times Cited: 3

MBNL splicing factors regulate the microtranscriptome of skeletal muscles
Agnieszka Piasecka, Michał Wojciech Szcześniak, Michał Sekrecki, et al.
Nucleic Acids Research (2024)
Open Access | Times Cited: 3

Long-Term Systemic Treatment of a Mouse Model Displaying Chronic FSHD-like Pathology with Antisense Therapeutics That Inhibit DUX4 Expression
Ngoc Lu‐Nguyen, George Dickson, Alberto Malerba, et al.
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1623-1623
Open Access | Times Cited: 12

Improving Molecular and Histopathology in Diaphragm Muscle of the Double Transgenic ACTA1-MCM/FLExDUX4 Mouse Model of FSHD with Systemic Antisense Therapy
Ngoc Lu‐Nguyen, Alberto Malerba, Marina Antoni Pineda, et al.
Human Gene Therapy (2022) Vol. 33, Iss. 17-18, pp. 923-935
Closed Access | Times Cited: 11

268th ENMC workshop - Genetic diagnosis, clinical classification, outcome measures, and biomarkers in Facioscapulohumeral Muscular Dystrophy (FSHD): Relevance for clinical trials
Federica Montagnese, Katy de Valle, Richard J.L.F. Lemmers, et al.
Neuromuscular Disorders (2023) Vol. 33, Iss. 5, pp. 447-462
Open Access | Times Cited: 6

Analysis of plasma‐derived small extracellular vesicle characteristics and microRNA cargo following exercise‐induced skeletal muscle damage in men
Jason Lovett, Rhys Stewart. McColl, Peter Durcan, et al.
Physiological Reports (2024) Vol. 12, Iss. 18
Open Access | Times Cited: 1

FSHD Therapeutic Strategies: What Will It Take to Get to Clinic?
Charis L. Himeda, Peter L. Jones
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 865-865
Open Access | Times Cited: 7

Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies
José Luis García‐Gimenez, Elena R. García‐Trevijano, Ana Isabel Avilés‐Alía, et al.
Orphanet Journal of Rare Diseases (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 7

Proximity ligation assay to detect DUX4 protein in FSHD1 muscle: a pilot study
Mary Lou Beermann, Sachiko Homma, Jeffrey B. Miller
BMC Research Notes (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 5

Muscle eosinophilia is a hallmark of chronic disease in facioscapulohumeral muscular dystrophy
Andreia M. Nunes, Monique Ramirez, Enrique Garcia-Collazo, et al.
Human Molecular Genetics (2024) Vol. 33, Iss. 10, pp. 872-883
Open Access

Systemic Pharmacotherapeutic Treatment of the ACTA1-MCM/FLExDUX4 Preclinical Mouse Model of FSHD
Ngoc Lu‐Nguyen, Stuart G. Snowden, Linda Popplewell, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6994-6994
Open Access

A novel family of lncRNAs relate facioscapulohumeral muscular dystrophy to nucleolar architecture and protein synthesis rate
Valentina Salsi, Francesca Losi, Bruno Fosso, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

Molecular, Histological, and Functional Changes in Acta1-MCM;FLExDUX4/+ Mice
Solene Sohn, Sophie Reid, Maximilien Bowen, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11377-11377
Open Access

Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping
Nikki M. McCormack, Kelsey A Calabrese, Christina M Sun, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay Proteomics
Amy E. Campbell, Jamshid Arjomand, Oliver D. King, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 6, pp. 1031-1040
Open Access | Times Cited: 1

First person – Andreia Nunes

Disease Models & Mechanisms (2021) Vol. 14, Iss. 8
Open Access

Page 1

Scroll to top